Literature DB >> 16271513

IL-12 reverses anergy to T cell receptor triggering in human lung tumor-associated memory T cells.

Lori Broderick1, Stephen P Brooks, Hiroshi Takita, Alan N Baer, Joel M Bernstein, Richard B Bankert.   

Abstract

Memory T cells in human non-small cell lung cancer are unresponsive to progressing tumors. T cells were evaluated at the single cell level by imaging the nuclear translocation of NF-kappaB and NFAT via immunofluorescence confocal microscopy as an early measure of responsiveness to T cell receptor triggering. Little translocation of NF-kappaB or NFAT occurred in tumor-associated T cells in response to CD3+CD28 cross-linking under conditions which led to maximal translocation in normal donor peripheral blood T cells. TNF-alpha induced maximal NF-kappaB translocation in these T cells, indicating that they remain receptive to alternative signaling pathways, and pulsing with IL-12 prior to TCR triggering reversed their apparent anergy. T cells from additional chronic inflammatory microenvironments demonstrated a similar refractoriness to TCR activation, suggesting either that a common regulatory mechanism present within the microenvironment controls these cells or that with continuous antigen exposure, they remain refractory to activation via the TCR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16271513     DOI: 10.1016/j.clim.2005.09.008

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  27 in total

1.  Memory T cells in the chronic inflammatory microenvironment of nasal polyposis are hyporesponsive to signaling through the T cell receptor.

Authors:  Heather K Lehman; Michelle R Simpson-Abelson; Thomas F Conway; Raymond J Kelleher; Joel M Bernstein; Richard B Bankert
Journal:  J Assoc Res Otolaryngol       Date:  2012-02-04

2.  Exosomes Associated with Human Ovarian Tumors Harbor a Reversible Checkpoint of T-cell Responses.

Authors:  Gautam N Shenoy; Jenni Loyall; Orla Maguire; Vandana Iyer; Raymond J Kelleher; Hans Minderman; Paul K Wallace; Kunle Odunsi; Sathy V Balu-Iyer; Richard B Bankert
Journal:  Cancer Immunol Res       Date:  2018-01-04       Impact factor: 11.151

3.  Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection.

Authors:  César Evaristo; Stefani Spranger; Sarah E Barnes; Michelle L Miller; Luciana L Molinero; Frederick L Locke; Thomas F Gajewski; Maria-Luisa Alegre
Journal:  J Immunol       Date:  2016-02-22       Impact factor: 5.422

4.  T cells and stromal fibroblasts in human tumor microenvironments represent potential therapeutic targets.

Authors:  Jennifer L Barnas; Michelle R Simpson-Abelson; Sandra J Yokota; Raymond J Kelleher; Richard B Bankert
Journal:  Cancer Microenviron       Date:  2010-03-31

5.  Sialic Acid-Dependent Inhibition of T Cells by Exosomal Ganglioside GD3 in Ovarian Tumor Microenvironments.

Authors:  Gautam N Shenoy; Jenni Loyall; Charles S Berenson; Raymond J Kelleher; Vandana Iyer; Sathy V Balu-Iyer; Kunle Odunsi; Richard B Bankert
Journal:  J Immunol       Date:  2018-11-16       Impact factor: 5.422

6.  Exosomes Represent an Immune Suppressive T Cell Checkpoint in Human Chronic Inflammatory Microenvironments.

Authors:  Gautam N Shenoy; Maulasri Bhatta; Jenni L Loyall; Raymond J Kelleher; Joel M Bernstein; Richard B Bankert
Journal:  Immunol Invest       Date:  2020-04-17       Impact factor: 3.657

Review 7.  Biochemical signaling pathways for memory T cell recall.

Authors:  Donna L Farber
Journal:  Semin Immunol       Date:  2009-04       Impact factor: 11.130

8.  Alteration of the immunological synapse in lung cancer: a microenvironmental approach.

Authors:  S Derniame; J-M Vignaud; G C Faure; M C Béné
Journal:  Clin Exp Immunol       Date:  2008-08-29       Impact factor: 4.330

9.  IL-12 delivered intratumorally by multilamellar liposomes reactivates memory T cells in human tumor microenvironments.

Authors:  Michelle R Simpson-Abelson; Vivek S Purohit; Wing Man Pang; Vandana Iyer; Kunle Odunsi; Todd L Demmy; Sandra J Yokota; Jenni L Loyall; Raymond J Kelleher; Sathy Balu-Iyer; Richard B Bankert
Journal:  Clin Immunol       Date:  2009-04-22       Impact factor: 3.969

10.  IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions.

Authors:  Irma Airoldi; Emma Di Carlo; Claudia Cocco; Emanuela Caci; Michele Cilli; Carlo Sorrentino; Gabriella Sozzi; Silvano Ferrini; Sandra Rosini; Giulia Bertolini; Mauro Truini; Francesco Grossi; Luis Juan Vicente Galietta; Domenico Ribatti; Vito Pistoia
Journal:  PLoS One       Date:  2009-07-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.